Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TCA8113 |
Human oral squamous cell carcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. Xu et al., PLoS ONE, 2015, 10(3):e0121439; doi:10.1371/journal.pone.0121439 | Link | ||
TCA8113 |
Human oral squamous cell carcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | M. Xu et al., PLoS ONE, 2015, 10(3):e0121439; doi:10.1371/journal.pone.0121439 | Link | |||
TAM6 |
Human breast adenocarcinoma cell line (MCF-7 clone) | Human | breast | cell line | adherent | miRNA | K2 Transfection System | publication | B. Ljepoja et al.,The Breast, 2019, 43: 31-38, doi.org/10.1016/j.breast.2018.10.007 | Link | |||
TAM6 |
Human breast adenocarcinoma cell line (MCF-7 clone) | Human | breast | cell line | adherent | plasmid | K2 Transfection System | publication | B. Ljepoja et al.,The Breast, 2019, 43: 31-38, doi.org/10.1016/j.breast.2018.10.007 | Link | |||
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | plasmid | Metafectene | publication | D. Guardavaccaro, Dissertation, 2012, Universita degli Studi della Tuscia | Link | ||
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | A. G. Mitrakas et al., Cancer Biol. Med., 2018, 15(3): 260-276, doi: 10.20892/j.issn.2095-3941.2017.0173 | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. M. McDonell et al., Nat. Genet., 2013, 45(5): 556–562, doi:10.1038/ng.2602 | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | C. Wanka et al., J. Biol. Chem., Sep 2012; 287: 33436 - 33446 | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | G. D. Maurer et al., Neuro Oncology, Dec 2009; 11: 747 - 756 | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | application note | ![]() |
||
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | D. Alcantara, PhD Thesis, 2012, University of Sussex | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M.C. Burger et al., Int. J. of Oncology, 2012, 41: 235-241, DOI: 10.3892/ijo.2012.1446 | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Alagoz et al., Nucleic Acids Res., Mar 2014; 42: 3089 - 3103 | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | D. Guardavaccaro, Dissertation, 2012, Universita degli Studi della Tuscia | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | plasmid | Metafectene | publication | Z. Ping et al., Cell Cycle, 2012, 11: 10, 1999-2005, doi.org/10.4161/cc.20402 | Link | ||
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | A. G. Mitrakas et al., Cancer Biol. Med., 2018, 15(3): 260-276, doi: 10.20892/j.issn.2095-3941.2017.0173 | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | W. C. Brucker et al., Zurich Open Repository and Archive, University of Zurich, 2012, doi.org/10.1038/onc.2011.530 | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | G. D. Maurer et al., Neuro Oncology, Dec 2009; 11: 747 - 756 | Link | |
T98 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. B. Morelli et al., Oncotarget, 2016, 7 (28): 43654-43668 | Link | ||
T97 |
Human uveal melanoma cell line | Human | skin | cell line | adherent | plasmid | K2 Transfection System | publication | M. Benhassine et al., Int. J. Mol. Sci., 2018, 19: 3272, doi:10.3390/ijms19103272 | Link | |||
T143 |
Human uveal melanoma cell line | Human | skin | cell line | adherent | plasmid | K2 Transfection System | publication | M. Benhassine et al., Int. J. Mol. Sci., 2018, 19: 3272, doi:10.3390/ijms19103272 | Link | |||
T142 |
Human uveal melanoma cell line | Human | skin | cell line | adherent | plasmid | K2 Transfection System | publication | M. Benhassine et al., Int. J. Mol. Sci., 2018, 19: 3272, doi:10.3390/ijms19103272 | Link | |||
T108 |
Human uveal melanoma cell line | Human | skin | cell line | adherent | plasmid | K2 Transfection System | publication | M. Benhassine et al., Int. J. Mol. Sci., 2018, 19: 3272, doi:10.3390/ijms19103272 | Link | |||
T-REx-293 |
Human embryonic kidney cell line, stably expressing tetracycline repressor (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | S.-B. M. Varda et al., 2012, WO 2007/043049 | Link |